Scholarly Index
Edmund J. Lewis
NKT Therapeutics (United States); 27,584 total citations; 209 total publications; best world rank #85
NKT Therapeutics (United States)
27,584Total citations
209Total publications
70H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal Diseases and Glomerulopathies | Lifetime | 85 | US 40 | 99.38 |
| Systemic Lupus Erythematosus Research | Lifetime | 331 | US 126 | 98.92 |
| Chronic Kidney Disease and Diabetes | Lifetime | 194 | US 93 | 98.81 |
| Blood Pressure and Hypertension Studies | Lifetime | 548 | US 225 | 98.43 |
| Complement system in diseases | Lifetime | 337 | US 129 | 96.88 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 318 | US 150 | 96.27 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 596 | US 221 | 96.42 |
| Vasculitis and related conditions | Lifetime | 454 | US 125 | 96.06 |
| Renin-Angiotensin System Studies | Lifetime | 528 | US 211 | 95.49 |
| Systemic Sclerosis and Related Diseases | Lifetime | 970 | US 282 | 94.23 |
| Macrophage Migration Inhibitory Factor | Lifetime | 672 | US 272 | 84.40 |